These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

951 related items for PubMed ID: 28423652

  • 1. Suppressive role exerted by microRNA-29b-1-5p in triple negative breast cancer through SPIN1 regulation.
    Drago-Ferrante R, Pentimalli F, Carlisi D, De Blasio A, Saliba C, Baldacchino S, Degaetano J, Debono J, Caruana-Dingli G, Grech G, Scerri C, Tesoriere G, Giordano A, Vento R, Di Fiore R.
    Oncotarget; 2017 Apr 25; 8(17):28939-28958. PubMed ID: 28423652
    [Abstract] [Full Text] [Related]

  • 2. The microRNA-381(miR-381)/Spindlin1(SPIN1) axis contributes to cell proliferation and invasion of colorectal cancer cells by regulating the Wnt/β-catenin pathway.
    Zhou L, Wang H, Fang Z, Zhong M, He Y, Zou J, Huang S, Li J, Xiang X, Fang Z.
    Bioengineered; 2021 Dec 25; 12(2):12036-12048. PubMed ID: 34753384
    [Abstract] [Full Text] [Related]

  • 3. Suppression of SPIN1-mediated PI3K-Akt pathway by miR-489 increases chemosensitivity in breast cancer.
    Chen X, Wang YW, Xing AY, Xiang S, Shi DB, Liu L, Li YX, Gao P.
    J Pathol; 2016 Aug 25; 239(4):459-72. PubMed ID: 27171498
    [Abstract] [Full Text] [Related]

  • 4. A loop involving NRF2, miR-29b-1-5p and AKT, regulates cell fate of MDA-MB-231 triple-negative breast cancer cells.
    De Blasio A, Di Fiore R, Pratelli G, Drago-Ferrante R, Saliba C, Baldacchino S, Grech G, Scerri C, Vento R, Tesoriere G.
    J Cell Physiol; 2020 Feb 25; 235(2):629-637. PubMed ID: 31313842
    [Abstract] [Full Text] [Related]

  • 5. miR-199a-5p confers tumor-suppressive role in triple-negative breast cancer.
    Chen J, Shin VY, Siu MT, Ho JC, Cheuk I, Kwong A.
    BMC Cancer; 2016 Nov 14; 16(1):887. PubMed ID: 27842518
    [Abstract] [Full Text] [Related]

  • 6. MiR-1271 as a tumor suppressor in breast cancer proliferation and progression via targeting SPIN1.
    Du HY, Liu B.
    Eur Rev Med Pharmacol Sci; 2018 May 14; 22(9):2697-2706. PubMed ID: 29771421
    [Abstract] [Full Text] [Related]

  • 7. CircWHSC1 regulates malignancy and glycolysis by the miR-212-5p/AKT3 pathway in triple-negative breast cancer.
    Ding L, Xie Z.
    Exp Mol Pathol; 2021 Dec 14; 123():104704. PubMed ID: 34624276
    [Abstract] [Full Text] [Related]

  • 8. STAT3-induced HLA-F-AS1 promotes cell proliferation and stemness characteristics in triple negative breast cancer cells by upregulating TRABD.
    Wu D, Jia H, Zhang Z, Li S.
    Bioorg Chem; 2021 Apr 14; 109():104722. PubMed ID: 33618253
    [Abstract] [Full Text] [Related]

  • 9. Overexpression of miR-361-5p in triple-negative breast cancer (TNBC) inhibits migration and invasion by targeting RQCD1 and inhibiting the EGFR/PI3K/Akt pathway.
    Han J, Yu J, Dai Y, Li J, Guo M, Song J, Zhou X.
    Bosn J Basic Med Sci; 2019 Feb 12; 19(1):52-59. PubMed ID: 29924958
    [Abstract] [Full Text] [Related]

  • 10. Long noncoding RNA GAS5 suppresses triple negative breast cancer progression through inhibition of proliferation and invasion by competitively binding miR-196a-5p.
    Li S, Zhou J, Wang Z, Wang P, Gao X, Wang Y.
    Biomed Pharmacother; 2018 Aug 12; 104():451-457. PubMed ID: 29793177
    [Abstract] [Full Text] [Related]

  • 11. miR-489 inhibits proliferation, cell cycle progression and induces apoptosis of glioma cells via targeting SPIN1-mediated PI3K/AKT pathway.
    Li Y, Ma X, Wang Y, Li G.
    Biomed Pharmacother; 2017 Sep 12; 93():435-443. PubMed ID: 28666210
    [Abstract] [Full Text] [Related]

  • 12. LncRNA FAM83H-AS1 promotes triple-negative breast cancer progression by regulating the miR-136-5p/metadherin axis.
    Han C, Fu Y, Zeng N, Yin J, Li Q.
    Aging (Albany NY); 2020 Feb 17; 12(4):3594-3616. PubMed ID: 32074085
    [Abstract] [Full Text] [Related]

  • 13. microRNA-761 induces aggressive phenotypes in triple-negative breast cancer cells by repressing TRIM29 expression.
    Guo GC, Wang JX, Han ML, Zhang LP, Li L.
    Cell Oncol (Dordr); 2017 Apr 17; 40(2):157-166. PubMed ID: 28054302
    [Abstract] [Full Text] [Related]

  • 14. miR-17-5p suppresses cell proliferation and invasion by targeting ETV1 in triple-negative breast cancer.
    Li J, Lai Y, Ma J, Liu Y, Bi J, Zhang L, Chen L, Yao C, Lv W, Chang G, Wang S, Ouyang M, Wang W.
    BMC Cancer; 2017 Nov 10; 17(1):745. PubMed ID: 29126392
    [Abstract] [Full Text] [Related]

  • 15. MicroRNA-582-5p promotes triple-negative breast cancer invasion and metastasis by antagonizing CMTM8.
    Zeng X, Ma X, Guo H, Wei L, Zhang Y, Sun C, Han N, Sun S, Zhang N.
    Bioengineered; 2021 Dec 10; 12(2):10126-10135. PubMed ID: 34978519
    [Abstract] [Full Text] [Related]

  • 16. MicroRNA-101 inhibits cell progression and increases paclitaxel sensitivity by suppressing MCL-1 expression in human triple-negative breast cancer.
    Liu X, Tang H, Chen J, Song C, Yang L, Liu P, Wang N, Xie X, Lin X, Xie X.
    Oncotarget; 2015 Aug 21; 6(24):20070-83. PubMed ID: 26036638
    [Abstract] [Full Text] [Related]

  • 17. MicroRNA-211-5p suppresses tumour cell proliferation, invasion, migration and metastasis in triple-negative breast cancer by directly targeting SETBP1.
    Chen LL, Zhang ZJ, Yi ZB, Li JJ.
    Br J Cancer; 2017 Jun 27; 117(1):78-88. PubMed ID: 28571042
    [Abstract] [Full Text] [Related]

  • 18. Identification of the Novel Tumor Suppressor Role of FOCAD/miR-491-5p to Inhibit Cancer Stemness, Drug Resistance and Metastasis via Regulating RABIF/MMP Signaling in Triple Negative Breast Cancer.
    Huang WC, Chi HC, Tung SL, Chen PM, Shih YC, Huang YC, Chu PY.
    Cells; 2021 Sep 24; 10(10):. PubMed ID: 34685504
    [Abstract] [Full Text] [Related]

  • 19. SPIN1, negatively regulated by miR-148/152, enhances Adriamycin resistance via upregulating drug metabolizing enzymes and transporter in breast cancer.
    Chen X, Wang YW, Gao P.
    J Exp Clin Cancer Res; 2018 May 09; 37(1):100. PubMed ID: 29743122
    [Abstract] [Full Text] [Related]

  • 20. miR-221/222 activate the Wnt/β-catenin signaling to promote triple-negative breast cancer.
    Liu S, Wang Z, Liu Z, Shi S, Zhang Z, Zhang J, Lin H.
    J Mol Cell Biol; 2018 Aug 01; 10(4):302-315. PubMed ID: 30053090
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 48.